145 results match your criteria: "Keiyukai Sapporo Hospital[Affiliation]"

Article Synopsis
  • * Most patients received paclitaxel-based treatments (49%), followed by fluoropyrimidines plus platinum (44%), and irinotecan (7%), with overall response rates of 28.7% and disease control rates of 54.1%.
  • * Results indicated a median progression-free survival (PFS) of 5.1 months and overall survival (OS) of 12.9 months, with the combination of paclitaxel and ramucirumab
View Article and Find Full Text PDF
Article Synopsis
  • This study examined factors that predict how well head and neck cancer patients respond to nivolumab, an anti-PD-1 treatment, focusing on clinical, microenvironmental, and genomic aspects.
  • It analyzed 100 patients, revealing that responders typically had lower smoking and drinking habits, more immune-related side effects, and higher PD-L1 expression compared to non-responders.
  • Additionally, factors like age, previous treatment with cetuximab, and specific gene mutations affected the response to treatment, highlighting the complexity of immune responses in cancer therapy.
View Article and Find Full Text PDF
Article Synopsis
  • In Asia, adjuvant chemotherapy combined with nivolumab post-gastrectomy is being assessed for effectiveness and safety in treating pathological stage III gastric or gastro-oesophageal junction cancer.
  • The ATTRACTION-5 trial involved a randomized, double-blind study across 96 hospitals in East Asia, enrolling patients aged 20-80 with confirmed stage IIIA-C cancer following specific surgeries.
  • Patients were divided into two groups to receive either nivolumab with chemotherapy or a placebo with chemotherapy, with the main focus on measuring relapse-free survival and analyzing safety data.
View Article and Find Full Text PDF

Clinical and Diagnostic Utility of Genomic Profiling for Digestive Cancers: Real-World Evidence from Japan.

Cancers (Basel)

April 2024

Genomics Unit, Keio Cancer Center, Keio University School of Medicine, Integrated Medical Research Building 3-S5, 35, Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.

Article Synopsis
  • A large-scale study in Japan aimed to evaluate the effectiveness of comprehensive genomic profiling (CGP) for diagnosing digestive cancers, including data from 547 patients with various cancer types.
  • The study developed a scoring system to identify significant genomic alterations, finding high detection rates for potentially actionable genomic changes (99.5%) and actionable alterations (62.5%).
  • The results highlighted that most digestive cancers were adenocarcinomas, and a proposed classification flowchart could help improve diagnosis, demonstrating CGP's clinical utility in managing digestive cancers.
View Article and Find Full Text PDF

Esophageal cancer in an adult with congenital esophageal stenosis: a case report.

Surg Case Rep

March 2024

Department of Gastroenterological Surgery, Keiyukai Sapporo Hospital, Minami1-1, Hondori 9-Chome, Shiroishi-Ku, Sapporo, 003-0026, Japan.

Background: Congenital esophageal stenosis (CES) is a rare condition. We encountered a case of esophageal cancer that developed in an adult with persistent CES. Although many studies have investigated the therapeutic outcomes and performed surveillance for symptoms after treatment for CES, few have performed long-term surveillance or reported on the development of esophageal cancer.

View Article and Find Full Text PDF

Introduction: Since patients with pharyngeal squamous cell carcinoma (SCC) often have multiple pharyngeal lesions, evaluation of pharyngeal lesions before endoscopic resection (ER) is important. However, detailed endoscopic observation of the entire pharyngeal mucosa under conscious sedation is difficult. We examined the usefulness of endoscopic surveillance with narrow band imaging (NBI) and lugol staining for detection of pharyngeal sublesions during ER for pharyngeal SCC under general anesthesia (endoscopic surveillance during treatment; ESDT).

View Article and Find Full Text PDF

Purpose: We investigated whether twice-daily administration of a bilayer tablet formulation of tramadol (35% immediate-release [IR] and 65% sustained-release) is as effective as four-times-daily IR tramadol capsules for managing cancer pain.

Methods: This randomized, double-blind, double-dummy, active-comparator, non-inferiority study enrolled opioid-naïve patients using non-steroidal anti-inflammatory drugs or acetaminophen (paracetamol) to manage cancer pain and self-reported pain (mean value over 3 days ≥ 25 mm on a 100-mm visual analog scale [VAS]). Patients were randomized to either bilayer tablets or IR capsules for 14 days.

View Article and Find Full Text PDF

Few objective evaluations of external auditory canal movement during mastication have been conducted. This study investigated the extent to which age and physical properties influence such movement. The effects of food properties and aging on ear canal movement during mastication were investigated using an earable reliable chewing-count measurement device.

View Article and Find Full Text PDF

Background: Postoperative adjuvant chemotherapy with S-1 for 1 year (corresponding to eight courses) is the standard treatment for pathological stage II gastric cancer. The phase III trial (JCOG1104) investigating the non-inferiority of four courses of S-1 to eight courses was terminated due to futility at the first interim analysis. To confirm the primary results, we reported the results after a 5-years follow-up in JCOG1104.

View Article and Find Full Text PDF
Article Synopsis
  • Laparoscopic gastrectomy (LG) is a common treatment for early-stage gastric cancer, but it has limitations like motion restriction and spatial perception issues, which robot-assisted gastrectomy (RG) aims to overcome through advanced features.
  • A large-scale randomized phase III study is being conducted in Japan to determine if RG is safer than LG for patients with clinical T1-2N0-2 gastric cancer, enrolling 1,040 participants over five years.
  • The study focuses on various postoperative complications and outcomes, including infection rates and survival, with approval obtained from healthcare authorities and adjustments made to eligibility criteria based on recent findings.
View Article and Find Full Text PDF

Background: Data regarding treatment sequence for vulnerable patients with metastatic colorectal cancer (mCRC) in a real-world setting are lacking.

Objective: We aimed to assess treatment outcomes in second-line or later chemotherapy for vulnerable patients with mCRC in a real-world setting.

Patients And Methods: Vulnerable patients with mCRC who received less intensive treatment ('vulnerable') regimens, i.

View Article and Find Full Text PDF

Background: Lung adenocarcinomas with micropapillary pattern (MP) or solid pattern (SP) have poor prognosis with frequent postoperative recurrence. However, treatment strategies for these histological subtypes have not been established. This study examined the recurrence rates and patterns in patients with these histological subtypes.

View Article and Find Full Text PDF

Introduction: Persistent descending mesocolon (PDM) is a rare congenital atypia of fixation of the descending colon, and currently, very few detailed studies exist on its vascular anatomy. This study was conducted to evaluate the features of the vascular anatomy of PDM to help avoid intraoperative lethal injury and subsequent postoperative complications in laparoscopic colorectal surgery.

Methods: We retrospectively analyzed the data of 534 patients who underwent laparoscopic left-sided colorectal surgery.

View Article and Find Full Text PDF

Background: Trifluridine/tipiracil (FTD/TPI) improved the overall survival in patients with metastatic colorectal cancer (mCRC) who had previously received standard chemotherapies; however, the clinical outcomes remain poor.

Objective: A multicenter phase II study aimed to assess the efficacy and safety of FTD/TPI plus cetuximab rechallenge.

Patients And Methods: Patients with histologically confirmed RAS wild-type mCRC refractory to prior anti-epidermal growth factor receptor (anti-EGFR) antibody were enrolled and treated with FTD/TPI (35 mg/m twice daily on days 1-5 and 8-12) plus cetuximab (initially 400 mg/m, followed by weekly 250 mg/m) every 4 weeks.

View Article and Find Full Text PDF

Regional Transcriptomics and Proteomics of Pharmacokinetics-Related Genes in Human Intestine.

Mol Pharm

June 2023

Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka 565-0871, Japan.

The intestine is an organ responsible for the absorption and metabolism of orally administered drugs. To predict pharmacokinetics behavior in the small intestine, it is necessary to examine the human intestinal expression profiles of the genes related to drug absorption, distribution, metabolism, and excretion (ADME). In this study, to obtain more accurate expression profiles in various regions of the human intestine, biopsy samples were collected from endoscopically noninflamed mucosa of the duodenum, jejunum, ileum, colon, and rectum from Japanese including Crohn's disease or ulcerative colitis patients, and both RNA-seq and quantitative proteomics analyses were performed.

View Article and Find Full Text PDF

Artificial Nerve Conduit for Recurrent Laryngeal Nerve Reconstruction in Thyroid Surgery.

Laryngoscope

July 2023

Department of Otolaryngology, Keiyukai Sapporo Hospital, Hondori 9 cho-me Minami 1-1, Shiroishi-ku, Sapporo, Hokkaido, 003-0026, Japan.

Objective: Oncological reconstruction of the recurrent laryngeal nerve (RLN) is sometimes necessary for RLN invaded by thyroid cancer. There have been no case reports of RLN reconstruction using artificial nerve conduits, which are often used for peripheral nerves. In this study, we retrospectively evaluate the feasibility, safety, and efficacy of a collagen conduit with collagen filaments for RLN reconstruction cases at our hospital.

View Article and Find Full Text PDF

There are a few reports that focus on radiotherapy (RT) and cetuximab (CET) therapy exclusively for oral cancer. This retrospective study aimed to investigate the efficacy and safety of RT and CET therapy for locally advanced (LA) or recurrent/metastatic (R/M) oral squamous cell carcinoma (OSCC). Seventy-nine patients from 13 hospitals who underwent RT and CET therapy for LA or R/M OSCC between January 2013 and May 2015 were enrolled in the study.

View Article and Find Full Text PDF
Article Synopsis
  • * A new treatment combo of encorafenib, binimetinib, and cetuximab has shown better response rates compared to standard chemotherapy for those with the V600E mutation.
  • * The TRESBIEN study (OGSG 2101) will investigate the effectiveness of this treatment in 25 patients with early recurrent V600E-mutated CRC, focusing on their condition during or after adjuvant chemotherapy.
View Article and Find Full Text PDF

Background: Bursectomy, the total resection of the bursa omentalis, is a standard procedure in gastrectomy for resectable gastric cancer. A phase III trial (JCOG1001) comparing bursectomy and omentectomy alone was terminated early at the interim analysis. The final results of the updated analysis after a minimum follow-up of 5 years are reported here.

View Article and Find Full Text PDF

Background: Accelerated tumor growth during immunotherapy in pre-existing measurable lesions, hyperprogressive disease (HPD), has been reported. However, progression of non-measurable lesions and new lesions are frequently observed in patients with advanced gastric cancer (AGC).

Methods: This retrospective study involved AGC patients at 24 Japanese institutions who had measurable lesions and received nivolumab after ≥ 2 lines of chemotherapy.

View Article and Find Full Text PDF

This clinical report describes the immediate autograft of primary (milk) teeth-derived demineralized dentin matrix (DDM) granules for a 6-year-old boy with unilateral alveolar cleft. First, four primary teeth were extracted, crushed in an electric mill for 1 min, and the crushed granules were demineralized in 2% HNO solution for 20 min. Simultaneously, the nasal mucoperiosteum was pushed upwards above the apices of the permanent central incisor adjacent to the cleft.

View Article and Find Full Text PDF

Background: The real-world survival benefit of FOLFOXIRI (fluorouracil, leucovorin, oxaliplatin, and irinotecan) plus anti-VEGF therapy (Triplet) over doublet chemotherapy (Doublet) remains controversial in patients with BRAF mutant metastatic colorectal cancer (mCRC).

Patients And Methods: WJOG13219G was a multicenter, retrospective, registry-based study of patients with BRAF mutant mCRC who received first-line triplet or doublet chemotherapy from January 2014 to December 2019 in Japan. Inverse probability of treatment weighting (IPTW) was used to adjust for patient background.

View Article and Find Full Text PDF
Article Synopsis
  • A multicenter retrospective study examined 69 patients with mucosal malignant melanoma (MM) of the oral cavity in Japan to analyze demographics and treatment outcomes from 2000 to 2020.
  • The study found that most patients were older men, with a mean age of about 70, and many had advanced disease stages, with 79.7% undergoing radical therapy.
  • Results indicated that early detection and radical treatment significantly improved survival rates, highlighting advanced T classification as a key prognostic factor for overall survival.
View Article and Find Full Text PDF

Background: Polymorphous adenocarcinoma is a common intraoral minor salivary gland carcinoma in Western countries but is extremely rare in Japan. The current study aimed to characterize the clinicopathological features and status of molecular alterations of polymorphous adenocarcinoma-associated genes, such as PRKD1/2/3, ARID1A, and DDX3X, in a large cohort of Japanese patients with polymorphous adenocarcinoma.

Methods: We examined the cases of 36 Japanese patients with salivary gland polymorphous adenocarcinoma and 26 cases involving histopathological mimics.

View Article and Find Full Text PDF

Background: Ramucirumab is a human IgG1 monoclonal vascular endothelial growth factor receptor-2 antibody that inhibits tumor cell growth and affects the tumor cell microenvironment. We assessed the efficacy and safety of ramucirumab plus irinotecan combination therapy as second-line treatment in patients with previously treated advanced gastric cancer.

Materials And Methods: Patients with advanced gastric cancer refractory or intolerant to primary chemotherapy were included.

View Article and Find Full Text PDF